ArticleBMC infectious diseases2025
Analysis of nosocomial infection characteristics in cancer patients after interventional therapy of 10 years: a retrospective study from 2013 to 2022.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInterventional therapy has been widely used in cancer patients as its advantages of minimally invasive, precise positioning and quick recovery. Nosocomial infections are the most common complication, but there are few reports about it. This study intends to analyze the characteristics of nosocomial infection patients after interventional therapy of the past 10 years, in order to provide guidances for the infection control.
methodsThe "Hospital Infection Real-time Monitoring System" was used to retrieve case information of patients undergoing intervention therapy from 2013 to 2022, and the general situation of the patients and infected patients was recorded in detail. Statistical software was used to analyze relevant indicators.
resultsFrom 2013 to 2022, a total of 12,343 hospitalized patients had 190 hospital infections, with an infection rate of 1.54%. The lowest hospital infection rate was 0.62% in 2022 and the highest was 2.76% in 2017, with a statistically significant difference (χ2 = 40.713, P = 0.000); Over the past 10 years, infection site in the bloodstream ranked first (46.98%), followed by surgical site infection (21.40%). Gram positive bacteria (50.75%) was the mainly pathogenic bacteria, followed by Gram negative bacteria (42.29%). Analysis of infection status shows that patients over 60 years old, undergone multiple (≥6) interventional surgeries, biliary tract pancreatic disease, liver cancer, and those who had undergone PTCD and TACE surgery have a higher infection rate.
conclusionsThe analysis of infection occurrence in patients of interventional therapy in 10 years can reflect the risk factors and high-risk links, which can help to take targeted control measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.